Viveve Medical (VIVE) Hits New 12-Month Low at $0.87
Shares of Viveve Medical Inc (NASDAQ:VIVE) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $0.87 and last traded at $0.87, with a volume of 167739 shares changing hands. The stock had previously closed at $0.90.
A number of research firms recently issued reports on VIVE. Raymond James lowered their target price on Viveve Medical from $4.50 to $3.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 12th. Craig Hallum set a $1.00 target price on Viveve Medical and gave the company a “hold” rating in a research report on Friday, January 18th. Finally, Maxim Group reaffirmed a “buy” rating on shares of Viveve Medical in a research report on Thursday, January 17th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $5.20.
The company has a quick ratio of 3.20, a current ratio of 3.72 and a debt-to-equity ratio of 3.42. The stock has a market cap of $28.70 million, a PE ratio of -0.41 and a beta of 0.71.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.watchlistnews.com/viveve-medical-vive-hits-new-12-month-low-at-0-87/2890691.html.
Viveve Medical Company Profile (NASDAQ:VIVE)
Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories.
See Also: Earnings Reports
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.